3 ASX Penny Stocks With Market Caps Above A$40M
Despite a cautious outlook from major U.S. retailers impacting Wall Street, the ASX200 is set to open slightly higher, reflecting a resilient Australian market. Penny stocks, while often considered relics of past market eras, continue to offer intriguing opportunities for investors seeking affordability and potential growth in smaller or newer companies. In this article, we explore three such penny stocks on the ASX that stand out due to their financial strength and resilience amidst current economic conditions.
Name
Share Price
Market Cap
Financial Health Rating
Embark Early Education (ASX:EVO)
A$0.80
A$146.79M
★★★★☆☆
LaserBond (ASX:LBL)
A$0.595
A$69.81M
★★★★★★
EZZ Life Science Holdings (ASX:EZZ)
A$1.93
A$91.04M
★★★★★★
Austin Engineering (ASX:ANG)
A$0.455
A$282.17M
★★★★★☆
IVE Group (ASX:IGL)
A$2.20
A$340.76M
★★★★☆☆
Helloworld Travel (ASX:HLO)
A$2.06
A$335.4M
★★★★★★
Dusk Group (ASX:DSK)
A$1.03
A$64.14M
★★★★★★
GTN (ASX:GTN)
A$0.525
A$103.1M
★★★★★★
MaxiPARTS (ASX:MXI)
A$1.78
A$98.46M
★★★★★★
SKS Technologies Group (ASX:SKS)
A$2.13
A$238.71M
★★★★★★
Click here to see the full list of 1,035 stocks from our ASX Penny Stocks screener.
Let's take a closer look at a couple of our picks from the screened companies.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Dreadnought Resources Limited is an Australian mineral exploration company with a market capitalization of A$49.02 million.
Operations: Dreadnought Resources Limited has not reported any revenue segments.
Market Cap: A$49.02M
Dreadnought Resources, with a market cap of A$49.02 million, remains pre-revenue and unprofitable, yet it shows potential through its self-funded explorer strategy focused on the high-grade Star of Mangaroon gold mine. The management and board are experienced with average tenures of 3.1 and 5.8 years respectively. Recent capital raises amounting to A$4.1 million bolster its cash runway, though volatility persists in share price movements over recent months. The company is debt-free but has limited short-term financial stability with assets covering liabilities only marginally beyond the immediate term despite additional capital influxes from equity offerings.
Get an in-depth perspective on Dreadnought Resources' performance by reading our balance sheet health report here.
Learn about Dreadnought Resources' future growth trajectory here.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: ReadyTech Holdings Limited offers technology-based solutions in Australia and has a market cap of A$395.27 million.
Operations: The company's revenue is derived from three primary segments: Workforce Solutions (A$30.74 million), Government and Justice (A$42.51 million), and Education and Work Pathways (A$40.55 million).
Market Cap: A$395.27M
ReadyTech Holdings, with a market cap of A$395.27 million, has demonstrated robust earnings growth, outperforming the software industry over the past year. Despite its stable weekly volatility and satisfactory net debt to equity ratio of 13.2%, the company faces challenges with short-term and long-term liabilities exceeding its assets. The company's earnings quality is high, supported by an experienced management team and board. Trading significantly below estimated fair value presents a potential opportunity for investors; however, low return on equity at 3.6% suggests room for improvement in profitability metrics despite forecasts indicating continued earnings growth of 25.55% annually.
Click here to discover the nuances of ReadyTech Holdings with our detailed analytical financial health report.
Understand ReadyTech Holdings' earnings outlook by examining our growth report.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Southern Cross Electrical Engineering Limited offers electrical, instrumentation, communications, security, and maintenance services to the resources, commercial, and infrastructure sectors in Australia with a market cap of A$490.22 million.
Operations: Southern Cross Electrical Engineering Limited has not reported any specific revenue segments.
Market Cap: A$490.22M
Southern Cross Electrical Engineering, with a market cap of A$490.22 million, has shown strong financial performance with earnings growing 42.3% over the past year and outperforming the construction industry average. The company is debt-free, eliminating concerns about interest coverage and enhancing its financial stability. Despite trading 30.3% below estimated fair value, its return on equity at 14.6% remains low compared to benchmarks. While short-term and long-term liabilities are well-covered by assets, dividend sustainability is unstable due to an inconsistent track record. The experienced management team further supports the company's operational resilience amidst stable weekly volatility.
Click here and access our complete financial health analysis report to understand the dynamics of Southern Cross Electrical Engineering.
Assess Southern Cross Electrical Engineering's future earnings estimates with our detailed growth reports.
Gain an insight into the universe of 1,035 ASX Penny Stocks by clicking here.
Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Jump on the AI train with fast growing tech companies forging a new era of innovation.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:DRE ASX:RDY and ASX:SXE.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Australia's Monash IVF reports second embryo incident in two months
(Reuters) -Australian fertility group Monash IVF on Tuesday reported a new incident related to an embryo transfer, within a couple of months after reporting a similar case where a doctor accidentally implanted the wrong embryo. The latest incident, which occurred on June 5 at the company's Clayton laboratory, has been reported to regulatory bodies and the company's insurer, Monash said, issuing an apology to the impacted couple. The company is also conducting an internal investigation. The firm added that it is implementing additional verification processes and patient confirmation safeguards to prevent similar incidents in the future. The clinic owner in April reported a similar incident where an Australian woman gave birth to a stranger's baby due to a Monash fertility doctor's error. Shares of Monash are down about 31% since the news. The mix-up has drawn attention to an industry that was largely self-regulated until recently and raised concerns about security protocols at IVF clinics. The facilities are regulated by a mix of Australian industry bodies and state government agencies.
Yahoo
2 hours ago
- Yahoo
Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia
BOSTON & SYDNEY, June 09, 2025--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced the introduction of a Management Liability Insurance Policy tailored expressly for Life Science, BioTech and Pharmaceutical (LBP) companies in Australia. "The new LBP Management Liability Policy reflects our commitment to Australia's thriving life sciences community and our deep understanding of the challenges start-ups face at every stage of their journey," said Jessica Jefferies, Underwriting Manager, National Brokers, Executive & Professional Lines, BHSI Australia. "Life Sciences is one of the most promising industries in Australia and we are thrilled to be able to provide an innovative solution to support the industry". BHSI's new LBP Management Liability Insurance Policy is specifically for the R&D ecosystem – all stakeholders in Australia's diverse and energetic life sciences sector. The new product offers enhanced cover tailored for life sciences companies, with coverage not found in standard Management Liability policies. BHSI's solution will extend cover and ensure Directors, Officers, Scientific and Medical Advisory Boards all get the benefit of cover as they develop cutting-edge solutions globally. With an understanding of the funding requirements, the product provides two key elements of protection, extending cover for private capital raisings, and not excluding cover in the event of the Company's insolvency. With many Australian life sciences companies looking abroad for clinical development, BHSI's offering has the ability to extend protection to U.S. exposures, recognising the frequent pursuit of FDA approvals by Australian firms. The new solution expands BHSI's existing Management Liability policy wording for private companies and not-for-profits. BHSI is a leading market for Directors and Officers Liability insurance for ASX-listed life sciences companies in Australia. This launch extends that expertise and forms part of BHSI's strategy to provide tailored support for biotech and pharmaceutical customers from start-up to scale. To learn more, contact Berkshire Hathaway Specialty Insurance Company (incorporated in Nebraska, USA) ABN 84 600 643 034, AFS Licence No. 466713 ( provides commercial property, casualty, healthcare professional liability, executive and professional lines, transactional liability, surety, marine, travel, programs, accident & health, medical stop loss, homeowners, and multinational insurance. The actual and final terms of coverage for all product lines may vary. Berkshire Hathaway Specialty Insurance Company holds financial strength ratings of A++ from AM Best and AA+ from Standard & Poor's. Based in Boston, Berkshire Hathaway Specialty Insurance has offices in Atlanta, Boston, Chicago, Columbia, Dallas, Houston, Indianapolis, Irvine, Los Angeles, New York, Plymouth Meeting, San Francisco, San Ramon, Seattle, Stevens Point, Adelaide, Auckland, Barcelona, Brisbane, Brussels, Calgary, Cologne, Dubai, Dublin, Frankfurt, Hamburg, Hong Kong, Kuala Lumpur, London, Lyon, Macau, Madrid, Manchester, Melbourne, Milan, Munich, Paris, Perth, Singapore, Stockholm, Sydney, Toronto, and Zurich. View source version on Contacts MEDIA CONTACTJoAnn Lee / +1 617.936.2937
Business Wire
2 hours ago
- Business Wire
Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia
BOSTON & SYDNEY--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced the introduction of a Management Liability Insurance Policy tailored expressly for Life Science, BioTech and Pharmaceutical (LBP) companies in Australia. 'The new LBP Management Liability Policy reflects our commitment to Australia's thriving life sciences community and our deep understanding of the challenges start-ups face at every stage of their journey,' said Jessica Jefferies, Underwriting Manager, National Brokers, Executive & Professional Lines, BHSI Australia. 'Life Sciences is one of the most promising industries in Australia and we are thrilled to be able to provide an innovative solution to support the industry'. BHSI's new LBP Management Liability Insurance Policy is specifically for the R&D ecosystem – all stakeholders in Australia's diverse and energetic life sciences sector. The new product offers enhanced cover tailored for life sciences companies, with coverage not found in standard Management Liability policies. BHSI's solution will extend cover and ensure Directors, Officers, Scientific and Medical Advisory Boards all get the benefit of cover as they develop cutting-edge solutions globally. With an understanding of the funding requirements, the product provides two key elements of protection, extending cover for private capital raisings, and not excluding cover in the event of the Company's insolvency. With many Australian life sciences companies looking abroad for clinical development, BHSI's offering has the ability to extend protection to U.S. exposures, recognising the frequent pursuit of FDA approvals by Australian firms. The new solution expands BHSI's existing Management Liability policy wording for private companies and not-for-profits. BHSI is a leading market for Directors and Officers Liability insurance for ASX-listed life sciences companies in Australia. This launch extends that expertise and forms part of BHSI's strategy to provide tailored support for biotech and pharmaceutical customers from start-up to scale. To learn more, contact Berkshire Hathaway Specialty Insurance Company (incorporated in Nebraska, USA) ABN 84 600 643 034, AFS Licence No. 466713 ( provides commercial property, casualty, healthcare professional liability, executive and professional lines, transactional liability, surety, marine, travel, programs, accident & health, medical stop loss, homeowners, and multinational insurance. The actual and final terms of coverage for all product lines may vary. Berkshire Hathaway Specialty Insurance Company holds financial strength ratings of A++ from AM Best and AA+ from Standard & Poor's. Based in Boston, Berkshire Hathaway Specialty Insurance has offices in Atlanta, Boston, Chicago, Columbia, Dallas, Houston, Indianapolis, Irvine, Los Angeles, New York, Plymouth Meeting, San Francisco, San Ramon, Seattle, Stevens Point, Adelaide, Auckland, Barcelona, Brisbane, Brussels, Calgary, Cologne, Dubai, Dublin, Frankfurt, Hamburg, Hong Kong, Kuala Lumpur, London, Lyon, Macau, Madrid, Manchester, Melbourne, Milan, Munich, Paris, Perth, Singapore, Stockholm, Sydney, Toronto, and Zurich.
